Gland Pharma Limited Board recommends a final dividend of INR 20 per equity share for the fiscal year ending March 31st, 2024, subject to the approval of its shareholders. The dividend, upon approval by the shareholders, will be paid within 30 days from the date of the 46th Annual General Meeting (AGM). The Record Date for the purpose of the 46th Annual General Meeting and payment of final dividend, if approved by shareholders will be August 16, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,816 INR | -0.81% | -1.62% | -5.64% |
20/06 | Fosun Pharma Trims Stake in Gland Pharma to 51.83% | MT |
18/06 | Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 3.58B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024